Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Schwid

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Clinical Therapeutics|November 24, 2007
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosisSteven R Schwid, Hillel S Panitch
Hypertension (Dallas, Tex. : 1979)|August 6, 2008
Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson diseaseWilliam B White, Phyllis Salzman, Steven R Schwid, et al.
Nature Clinical Practice. Neurology|February 6, 2009
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosisLahar R Mehta, Robert H Dworkin, Steven R Schwid
Neurology|December 29, 2005
Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1aSteven R Schwid, Michael D Decker, Maria Lopez-Bresnahan, et al.
Journal of Rehabilitation Research and Development|June 8, 2002
Fatigue in multiple sclerosis: current understanding and future directionsSteven R Schwid, Melissa Covington, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A randomized trial of memantine as treatment for spasticity in multiple sclerosisLahar R Mehta, Michael P McDermott, Andrew D Goodman, et al.
Journal of the Neurological Sciences|March 3, 2007
Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trialSteven R Schwid, Andrew D Goodman, Amy Weinstein, et al.
Pain|October 12, 2007
Pain associated with multiple sclerosis: systematic review and proposed classificationAlec B O'Connor, Steven R Schwid, David N Herrmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Cognitive fatigue during a test requiring sustained attention: a pilot studySteven R Schwid, Carolyn M Tyler, Eileen A Scheid, et al.
Journal of Rehabilitation Research and Development|October 19, 2007
Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injuryFabrisia Ambrosio, Michael L Boninger, Shirley G Fitzgerald, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Clinical Therapeutics|November 24, 2007
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: a multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon beta-1a for relapsing multiple sclerosisSteven R Schwid, Hillel S Panitch
Hypertension (Dallas, Tex. : 1979)|August 6, 2008
Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson diseaseWilliam B White, Phyllis Salzman, Steven R Schwid, et al.
Nature Clinical Practice. Neurology|February 6, 2009
Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosisLahar R Mehta, Robert H Dworkin, Steven R Schwid
Neurology|December 29, 2005
Immune response to influenza vaccine is maintained in patients with multiple sclerosis receiving interferon beta-1aSteven R Schwid, Michael D Decker, Maria Lopez-Bresnahan, et al.
Journal of Rehabilitation Research and Development|June 8, 2002
Fatigue in multiple sclerosis: current understanding and future directionsSteven R Schwid, Melissa Covington, Benjamin M Segal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 24, 2009
A randomized trial of memantine as treatment for spasticity in multiple sclerosisLahar R Mehta, Michael P McDermott, Andrew D Goodman, et al.
Journal of the Neurological Sciences|March 3, 2007
Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trialSteven R Schwid, Andrew D Goodman, Amy Weinstein, et al.
Pain|October 12, 2007
Pain associated with multiple sclerosis: systematic review and proposed classificationAlec B O'Connor, Steven R Schwid, David N Herrmann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Cognitive fatigue during a test requiring sustained attention: a pilot studySteven R Schwid, Carolyn M Tyler, Eileen A Scheid, et al.
Journal of Rehabilitation Research and Development|October 19, 2007
Comparison of mobility device delivery within Department of Veterans Affairs for individuals with multiple sclerosis versus spinal cord injuryFabrisia Ambrosio, Michael L Boninger, Shirley G Fitzgerald, et al.
Pageof 3